Heart failure & cardiomyopathies

Clinical Phenotyping and Treatment Response in Patients With Chronic Heart Failure

JACC AdvPublished prospective multicenter cohort

Authors' conclusion

We identified 8 phenogroups with distinct clinical outcomes in patients with HF. This phenotyping provides appropriate risk stratification and may aid clinical decision-making in patients with HF.

Study context

Population
Chronic heart failure (HF) patients from the ELMSTAT-HF registry, enrolled between January 2020 and September 2024consecutive chronic HF patients examined, 2,317 patients enrolled in the registry
Participants
2,301 patients
Exposure
Incidence of the primary outcome between the 8 phenogroups
Outcome
Composite of:
  • All-cause death
  • Hospitalization for worsening HF
Follow-up
Median 597 (IQR: 302-932) days
Methodological detailsregistry, latent class analysis using 99 clinical features, consecutive patients
  • Registry
  • Latent class analysis using 99 clinical features
  • Consecutive patients

Main finding

As reported in the abstract

Incidence of the primary outcome significantly differed between the phenogroups
P < 0.001

Observational data: associations, not effects.

Further findings

Hospitalization for worsening HF in phenogroup 5, by beta-blocker or sodium-glucose cotransporter 2 inhibitor use

HR (95% CI)
Patients taking beta-blockers2.20 (1.04–4.68)
Patients taking sodium-glucose cotransporter 2 inhibitors4.27 (2.02–9.05)
  • Hospitalization for worsening HF in phenogroup 5, by beta-blocker or sodium-glucose cotransporter 2 inhibitor use: significantly higher rate of hospitalization for worsening HF; comparator not stated
  • Hospitalization for worsening HF in phenogroup 5, by beta-blocker or sodium-glucose cotransporter 2 inhibitor use: significantly higher rate of hospitalization for worsening HF; comparator not stated

Original publication

Clinical Phenotyping and Treatment Response in Patients With Chronic Heart Failure. JACC Adv. Published 17 July 2025. doi:10.1016/j.jacadv.2025.101972

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.